Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 08 2025
0mins
Source: Benzinga
Amplify ETFs Liquidation: Amplify ETFs announced the liquidation of the Amplify U.S. Alternative Harvest ETF (MJUS) due to a significant decline in its value, primarily caused by ongoing regulatory issues in the cannabis sector, with trading set to end on January 27.
Impact of DEA Regulations: The Drug Enforcement Administration's classification of marijuana as a Schedule I drug has hindered growth and investor confidence in cannabis-related funds, leading to poor performance across various cannabis ETFs amidst uncertainty surrounding potential rescheduling.
Analyst Views on MSOS
Wall Street analysts forecast MSOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 4.620
Low
Averages
High
Current: 4.620
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
